204 related articles for article (PubMed ID: 38486041)
1. Discovering therapeutic possibilities for polycystic ovary syndrome by targeting XIST and its associated ceRNA network through the analysis of transcriptome data.
Berenji E; Valipour Motlagh A; Fathi M; Esmaeili M; Izadi T; Rezvanian P; Zanjirband M; Safaeinejad Z; Nasr-Esfahani MH
Sci Rep; 2024 Mar; 14(1):6180. PubMed ID: 38486041
[TBL] [Abstract][Full Text] [Related]
2. The lncRNA-miRNA-mRNA ceRNA network in mural granulosa cells of patients with polycystic ovary syndrome: an analysis of Gene Expression Omnibus data.
Chen H; Cheng S; Xiong W; Tan X
Ann Transl Med; 2021 Jul; 9(14):1156. PubMed ID: 34430597
[TBL] [Abstract][Full Text] [Related]
3. Construction and analysis of a lncRNA (PWRN2)-mediated ceRNA network reveal its potential roles in oocyte nuclear maturation of patients with PCOS.
Huang X; Pan J; Wu B; Teng X
Reprod Biol Endocrinol; 2018 Aug; 16(1):73. PubMed ID: 30075721
[TBL] [Abstract][Full Text] [Related]
4. Identification of Crucial lncRNAs, miRNAs, mRNAs, and Potential Therapeutic Compounds for Polycystic Ovary Syndrome by Bioinformatics Analysis.
Zeng Z; Lin X; Xia T; Liu W; Tian X; Li M
Biomed Res Int; 2020; 2020():1817094. PubMed ID: 33224973
[TBL] [Abstract][Full Text] [Related]
5. Construction of a competing endogenous RNA network to identify drug targets against polycystic ovary syndrome.
Wu T; Gao YY; Tang XN; Li Y; Dai J; Zhou S; Wu M; Zhang JJ; Wang SX
Hum Reprod; 2022 Nov; 37(12):2856-2866. PubMed ID: 36223608
[TBL] [Abstract][Full Text] [Related]
6. Several critical genes and microRNAs associated with the development of polycystic ovary syndrome.
Wang W; Ji J; Li J; Ren Q; Gu J; Zhao Y; Hong D; Guo Q; Tan Y
Ann Endocrinol (Paris); 2020 Feb; 81(1):18-27. PubMed ID: 32127169
[TBL] [Abstract][Full Text] [Related]
7. Integrated bioinformatics analysis elucidates granulosa cell whole-transcriptome landscape of PCOS in China.
Li Q; Sang Y; Chen Q; Ye B; Zhou X; Zhu Y
J Ovarian Res; 2023 Aug; 16(1):154. PubMed ID: 37537636
[TBL] [Abstract][Full Text] [Related]
8. LncRNA XIST serves as a ceRNA to regulate the expression of ASF1A, BRWD1M, and PFKFB2 in kidney transplant acute kidney injury via sponging hsa-miR-212-3p and hsa-miR-122-5p.
Cheng Q; Wang L
Cell Cycle; 2020 Feb; 19(3):290-299. PubMed ID: 31914881
[TBL] [Abstract][Full Text] [Related]
9. Unveiling Key Biomarkers and Therapeutic Drugs in Polycystic Ovary Syndrome (PCOS) Through Pathway Enrichment Analysis and Hub Gene-miRNA Networks.
Heidarzadehpilehrood R; Pirhoushiaran M; Binti Osman M; Ling KH; Abdul Hamid H
Iran J Pharm Res; 2023; 22(1):e139985. PubMed ID: 38444712
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of lncRNA-miRNA-mRNA ceRNA network and key genes in granulosa cells of patients with biochemical primary ovarian insufficiency.
Liu B; Liu L; Sulaiman Z; Wang C; Wang L; Zhu J; Liu S; Cheng Z
J Assist Reprod Genet; 2024 Jan; 41(1):15-29. PubMed ID: 37847421
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA-X-inactive specific transcript inhibits cell viability, and induces apoptosis through the microRNA-30c-5p/Bcl2-like protein 11 signaling axis in human granulosa-like tumor cells.
Guo Y; Peng X; Cheng R; Chen H; Luo X
Bioengineered; 2022 Jun; 13(6):14107-14117. PubMed ID: 35730492
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics Analysis of ceRNA Network Related to Polycystic Ovarian Syndrome.
Li Y; Tan Y
Comput Math Methods Med; 2021; 2021():9988347. PubMed ID: 34211581
[TBL] [Abstract][Full Text] [Related]
13. Immune dysfunction mediated by the competitive endogenous RNA network in fetal side placental tissue of polycystic ovary syndrome.
Xie N; Wang F; Chen D; Zhou J; Xu J; Qu F
PLoS One; 2024; 19(3):e0300461. PubMed ID: 38512862
[TBL] [Abstract][Full Text] [Related]
14. Identification of a lncRNA/circRNA-miRNA-mRNA ceRNA Network in Alzheimer's Disease.
Su L; Zhang Y; Wang Y; Wei H
J Integr Neurosci; 2023 Oct; 22(6):136. PubMed ID: 38176923
[TBL] [Abstract][Full Text] [Related]
15. A Competing Endogenous RNA Network Reveals Novel lncRNA, miRNA and mRNA Biomarkers With Diagnostic and Prognostic Value for Early Breast Cancer.
Luo ZB; Lai GE; Jiang T; Cao CL; Peng T; Liu FE
Technol Cancer Res Treat; 2020; 19():1533033820983293. PubMed ID: 33371806
[TBL] [Abstract][Full Text] [Related]
16. Polycystic ovary syndrome: Identification of novel and hub biomarkers in the autophagy-associated mRNA-miRNA-lncRNA network.
Huang J; Huang B; Kong Y; Yang Y; Tian C; Chen L; Liao Y; Ma L
Front Endocrinol (Lausanne); 2022; 13():1032064. PubMed ID: 36523600
[TBL] [Abstract][Full Text] [Related]
17. Exosomal lncRNA and mRNA profiles in polycystic ovary syndrome: bioinformatic analysis reveals disease-related networks.
Zhou W; Zhang T; Lian Y; Zhang W; Yang M; Li Y; Wang L; Yan X
Reprod Biomed Online; 2022 May; 44(5):777-790. PubMed ID: 35337736
[TBL] [Abstract][Full Text] [Related]
18. The
Xu G; Mo L; Wu C; Shen X; Dong H; Yu L; Pan P; Pan K
Ren Fail; 2019 Nov; 41(1):955-966. PubMed ID: 31658856
[No Abstract] [Full Text] [Related]
19. Role of circular RNA/miRNA axes in the pathophysiology of polycystic ovary syndrome.
Ahmadi M; Fathi M; Malmir A; Ghafouri-Fard S
Mol Biol Rep; 2024 Mar; 51(1):437. PubMed ID: 38520572
[TBL] [Abstract][Full Text] [Related]
20. Differentially-expressed mRNAs, microRNAs and long noncoding RNAs in intervertebral disc degeneration identified by RNA-sequencing.
Li Z; Sun Y; He M; Liu J
Bioengineered; 2021 Dec; 12(1):1026-1039. PubMed ID: 33764282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
